Several studies have concluded that individuals with mutations in the apoCIII gene, which results in life-long lower levels of the apolipoprotein, are healthier with a favorable pattern of lipoproteins, increased insulin sensitivity, lower incidence of hypertension and they live longer [107,108,109,110]. This evidence concerns the gene INS and hypertensive disorder.